MGR001 / Advair Diskus Local Equivalence Study in Asthma

NCT02245672 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1128

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: MGR001 (Fixed dose combination of Fluticasone propionate and salmeterol xinafoate)
DRUG: Advair (Fixed dose combination of Fluticasone propionate and salmeterol xinafoate)
DRUG: Placebo

Sponsor

Mylan Pharma UK Ltd.